POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24h (1.25.2021, 10:26am CET, WHO):   The United States of America 170,883    India 13,203    Brazil 62,334    Russia 21,127    The United Kingdom 33,552    France 23,522    Italy 13,331    Germany 12,257    Columbia 15,551    Argentina 8,362    Mexico 20,057    Turkey 5,856    Poland 4,566    South Africa 12,271    Iran 5,945    Ukraine 3,915    Peru 5,842    Indonesia 11,788    The Netherlands 5,487    Czechia 4,256    Canada 5,124    Romania 2,719    Chile 4,463    Portugal 15,333    Pakistan 1,594    Philippines 1,940    Austria 1,551    Serbia 1,483    Japan 4,152    Hungary 1,257    Panama 2,058    Lebanon 3,010    United Arab Emirates 3,579    Ecuador 3,060    Slovakia 1,905    Belarus 1,748    Dominican Republic 1,439    Bolivia 1,732    Tunisia 2,059    Ireland 1,905    Malaysia 3,346    Slovenia 1,541    Honduras 1,056    Nigeria 2,464    Libya 1,148    Zambia 1,259    Cameroon 1,607    Malawi 1,076    China 205    Singapore 48    New Zealand 6    Australia 5    South Korea 437   

Russia to trial ‘light’ one-dose version of Sputnik jab

Christian Fernsby |
Russia will trial a one-dose version of its Sputnik V coronavirus vaccine, officials said on Monday, as they aim to provide a stopgap solution for badly hit countries.

Article continues below



Topics: RUSSIA    SPUTNIK   

The Russian Direct Investment Fund (RDIF), which financed the development of the two-dose Sputnik V jab, said it was also financing clinical trials of “Sputnik Light”, a less effective single-dose version.

RDIF head Kirill Dmitriyev told journalists the “one-component” version of Sputnik V could be an “effective temporary solution” for countries facing a high caseload of coronavirus infections.

The RDIF said in a statement on Monday that Palestinian authorities had also approved the vaccine for emergency use, with delivery planned for the first quarter of this year.


What to read next

Genetic testing can help determine safest dose of blood thinner
Anti-malarial shows promise in human clinical study
Russia approves Sputnik V vaccine use for people over 60